The genes of the transporter associated with antigen processing (Tap)-1, and the low molecular weight peptide (Lmp)-2, are crucial for class I major histocompatibility complex function and share a common bidirectional promoter. In murine bone marrow-derived macrophages, interferon gamma (IFN-g) induced Tap-1 and upregulated Lmp-2, which is constitutively expressed at low levels. The IFN-g-induction was independent of early gene synthesis. The mRNA induced by IFN-g was very stable. In macrophages from STAT1 knockout mice, IFN-g did not induce the expression of Tap-1 or Lmp-2. Several areas in the promoter can be controlled by IFN-g, such as proximal and distal GAS boxes in the direction of the Tap-1 gene, NFgB and IRF-1 boxes. By making deletions of the promoter, we found that only the proximal GAS and IRF-1 boxes are required for IFN-g induction of Tap-1 and Lmp-2. Experiments using nuclear extracts from macrophages treated for 30 min with IFN-g and gel shift analysis indicated that STAT1 binds to the GAS box. The nuclear extracts from macrophages treated for at least 2 h with IFN-g bound to the IRF-1 box. These results indicate that both STAT1 and IRF-1 are required for the IFN-g induction of Tap-1 and Lmp-2 genes.
Introduction
Cytotoxic T lymphocytes recognize and attack cells infected with virus or with tumor antigens on their surface via an interaction between the T-cell receptor and major histocompatibility complex (MHC) class I molecules loaded with 'non-self' peptides. 1, 2 The surface expression of HLA molecules requires the coordinated expression of several genes, such as the transporter associated with antigen processing (Tap)-1/2, the low molecular weight peptide (Lmp)-2/7, tapasin, as well as HLA class I heavy chain molecule and b 2 -microglobulin. 3 Lmp2 and Lmp7 are involved in breaking down intracellular proteins into antigenic peptides, while Tap1 and Tap2 contribute to the transport of these peptides from the cytosol to endoplasmic reticulum where they bind to the assembled MHC class I molecules. The MHC-peptide complex is then transported to the cell surface. Studies of Tap-deficient cell lines, mice with targeted disruptions of Tap genes and humans with Tap mutations have established that this transporter is essential for the expression of MHC class I molecules on the cell surface. 4, 5 Tap1 and Lmp2 genes are embedded in the class II region of the MHC locus. 6 They are transcribed from a shared bidirectional promoter and their ATG translation initiation codons are separated by only 596 bp. 7 Therefore, their expression is coordinated and a reduced expression and function of these two genes have been found in several distinct tumor types, 8 as well as reduced inducibility by interferon gamma (IFN-g) 9 or rapid degradation of mRNA. 10 Also, a reduced expression has been reported in animal models of autoimmune diabetes. 11, 12 The transcriptional regulation of the human bidirectional Tap1/Lmp2 promoter has not been fully analyzed and contradictory data has been reported. 7, 13, 14 Macrophages play a key role in immune response. IFN-g, which is released by activated T lymphocytes or NK cells, is the most potent activator of macrophages, and induces the expression of more than 300 genes, 15 which include Tap1 and Lmp2. 16 IFN-g exerts its effect by inducing the phosphorylation of STAT1, which then homodimerizes, thereby allowing it to interact with the IFN-g activation site (GAS) 17 or, in combination with p48 (IFN-stimulated gene factor 3 gamma, ISGF3 gamma), with the ISRE, by which it trans-activates genes that bear either of these sites in their promoter. 18 Transcription factors of the IFN regulatory factor (IRF) family, such as IRF-1, IRF-2 and IFN consensus sequence-binding proteins (ICSBP), are induced by this pathway. The ISRE binds factors of the IRF family, thereby mediating constitutive expression and cytokine induction of Tap1 and Lmp2 genes. 19 Despite the coordinated regulation of human Tap1 and Lmp2 genes in several cell lines, 20 ,21 it appears that binding of IRF-1 or STAT1 to ICS2/GAS is sufficient to regulate the transcription of the former gene, but the binding of both factors is required for transcription of the latter. 22 Given the interest in IFN-g as a macrophage activator and the crucial role of Tap1/Lmp2 genes in antigen processing, here we studied the regulation of these two genes in the murine system. Although there is a high homology between the Tap1/Lmp2 human and murine promoters, in the latter, STAT1 and IRF-1 are necessary to control the IFN-g-induced expression.
Results
Characterization of IFN-c induces Tap1 and Lmp2 mRNA expression in macrophages IFN-g induces mRNA expression of multiple genes involved in activation and regulation of the immune response. Here, we followed the steady state of Tap1 and Lmp2 mRNA in several types of murine macrophages as a function of time after stimulation with IFN-g ( Figure 1 ). A probe for the ribosomal protein L32 or the 18S, whose mRNA levels do not change after stimulation with IFN-g, was included as a control for each time point. The most notable feature was that the kinetics of the increased expression for each gene differed. A low level of Lmp2 but not Tap1 mRNA was detected in unstimulated cells and no increase was observed in the first 3 h after IFN-g treatment. After this time, a steady-state increase in mRNA levels of the two genes was observed throughout the remainder of the time course. By 24 h of incubation with IFN-g, the levels of Tap1 began to plateau, reaching a maximum while Lmp2 reached its maximum at 12 h. In the Raw 264.7 and Bac-1 F5a cells, the mRNA expression of these two genes increased under the effect of IFN-g ( Figure 1 ). These results indicate that increases in mRNA expression are not detected until cells have been stimulated with IFN-g for approximately 3 h, and that the induction increases with time, showing maximal expression after 24 h of treatment. Interestingly, the RAW cell line presented basal levels of mRNA for Lmp2 in unstimulated cells, which was not the case for Tap1.
To determine the basal expression of the Lmp-2 gene, quantitative RT-PCR was carried out using bone marrow macrophages. The results confirm the increased expression of Lmp-2 in basal conditions and the increase after 3 h in the expression levels of Tap-1 and Lmp-2 ( Figure 1) .
After 3 h of IFN-g treatment, Tap1 and Lmp2 mRNA levels began to increase. These genes are of intermediate expression, which suggests that their expression may require new protein factors, which should be synthesized in the cell during the first 3 h. To examine whether the increase in the level of mRNA induced by IFN-g required the synthesis of new proteins, cells were treated with IFN-g in the presence of 10 mg/ml of cycloheximide. This treatment produced a 490% reduction in the incorporation of [ 3 H]leucine into trichloroacetic acid-precipitable material. 23 Raw 264.7 cells were treated with cycloheximide 30 min before and during stimulation for 1 h with IFN-g, then cells were incubated in normal media and gene expression was analyzed by Northern Blot. The short treatment with cycloheximide was carried out because it is very toxic for macrophages. When mRNA expression was quantified using the amount of L32 gene expression as a reference, we observed that the preincubation of cells with cycloheximide reduces but does not block completely the induction of Tap1 and Lmp2 genes in response to IFN-g (Figure 2 ), suggesting that early gene synthesis (after 1 h of IFN-g treatment) is not required. As a control, we determined the IFN-g-dependent expression of the IA-a gene of MHC class II, which requires de novo protein synthesis. 24 Our results indicate that Tap1 and Lmp2 genes do not require synthesis of early genes for IFN-g-dependent induction.
In a cell line of human macrophages, IFN-g downregulates the expression of Tap1 mRNA by decreasing its half-life from 24 to 4 h. 16 To explore whether IFN-g treatment affects the stability of mRNA, we determined the half-life of the mRNA of these two genes in cells treated with IFN-g. To determine the rate of mRNA degradation, bone marrow-derived macrophages (BMDM) were treated with IFN-g for 24 h, thereby inducing Tap1 and Lmp2 mRNA (Figure 3) . Actinomycin D was then added at a concentration (5 mg/ml) sufficient to block all further mRNA synthesis, as determined by [ 3 H]UTP incorporation, 23 and mRNA was isolated from aliquots of cells at distinct intervals thereafter. Determination of the relative levels of Tap1 and Lmp2 mRNA after the addition of actinomycin D allowed us to estimate the half-life of these mRNAs. The steady-state levels of Tap1 and Lmp2 were very stable, since they did not vary even after 6 h of actinomycin D treatment. A probe for IL-1b, whose mRNA levels are very unstable, 25 was included as a control of transcription block by actinomycin D. The half-life for Tap1 and Lmp2 mRNA in resting cells was very stable (data not shown). Similar results were obtained when we used Raw 264.7 cells.
IFN-c-induced Tap1 and Lmp2 expression is STAT1-dependent
Most of the genes induced by the IFN-g signalling pathway are mediated by STAT1, which, after being phosphorylated, dimerizes and translocates to the nucleus. 16 However, IFN-g induces the expression of some genes in the absence of STAT1. 26 Since IFN-g induces Tap1 and Lmp2 gene expression, we questioned whether this protein STAT1 was involved in the signalling pathway that leads to the expression of these genes. We used BMDM from mice in which STAT1 expression (STAT1 knockout) has been inactivated. 27 Macrophages from wild-type (WT) or STAT1-deficient mice were stimulated with IFN-g for a range of times and specific mRNA was detected by Northern Blot. As 
Regulation of Tap1 and Lmp2 genes M Brucet et al
expected, in macrophages from WT animals, Tap1 mRNA was detectable 2 h after IFN-g treatment. Constitutive expression was observed for Lmp2 mRNA, but increased under the effect of IFN-g ( Figure 4 ). In macrophages from STAT1 knockouts, no expression of Tap1 and only basal expression of Lmp2 was detected. These data demonstrate that the IFN-g-induced expression of these two genes is STAT1-dependent.
Functional analysis of the promoter in the IFN-cmediated Tap1 and Lmp2 induction
Having observed the capacity of IFN-g to induce the expression of Tap1 and Lmp2 genes, and established the involvement of STAT1 in the signal transduction pathway, we next analyzed the functional activity of the promoter in order to delineate the critical sequence elements for this induction. The TFSEARCH program in the TRANSFAC databases was used to examine the promoter sequence for possible regulatory areas in which the transcription factor binds. 28 This analysis showed that the promoter region contains various putative sites for the binding of transcription factors involved in IFN-g signal transduction, such as two GAS boxes (GAS1 between À163 and À172 from the ATG translation initiation codon of Tap1 gene and GAS2 between À240 and À247) and the IRF-1 box (À177 to À187). In addition, we detected a NFkB box (À110 to À119). To examine the possible role of these putative areas, we determined the transcription steady state of the promoter in both directions. Using the promoter in the direction of Tap1 linked to the luciferase gene, we observed low luciferase activity when this construction was transfected into Raw 264.7 cells. Each construction was cotransfected together with the renilla expression vector. All luciferase activity values were normalized to the level of renilla expression to correct for any differences in transfection efficiency. The original construct containing the WT promoter (pGL3-tap) with 571 bp showed a little basal activity, but under the effect of IFN-g this expression increased four to five times (Figure 5a ). When the GAS1 or the IRF-1 boxes were mutated, the IFN-g inducibility was lost. These data indicate that in macrophages, the GAS1 and the IRF-1 regions are critical for the induction of Tap1 expression in response to IFN-g. On the other hand, mutation in the GAS2 site had no effect on the response to IFN-g stimulation. As the promoter also contains an NFkB site, we mutated this site and performed the same analysis. The NFkB box is not important for the induction of Tap1 expression in response to IFN-g.
The same constructs were made for the promoter cloned in the direction of the Lmp2 gene into the luciferase plasmid (pGL3-lmp) (Figure 5b ). This series of reporter plasmids were cotransfected into Raw 264.7 cells and luciferase activity was assayed after 24 h of 
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stimulation with IFN-g. The complete promoter for Lmp2 gene was induced 4.7-fold over basal levels by this treatment. When constructs containing mutated GAS1 and IRF-1 boxes were used, the reporter plasmids did not respond to stimulation. Again, no effect was observed when the GAS2 or NFkB boxes were mutated. In summary, these results demonstrate that GAS1 and IRF-1 elements are required for the response of the Tap1/ Lmp2 promoter to IFN-g stimulation. These findings confirm our observations using macrophages from the STAT1 knockout mice (Figure 4 ).
Identification of binding proteins to the GAS1 and IRF-1 boxes
To examine the proteins that bind to the areas of interest in the Tap1/Lmp2 promoter, gel electrophoresis DNA binding assays were performed. When nuclear extract prepared from BMDM treated with IFN-g and a probe covering the GAS1 box were used, two retarded bands were observed with extracts prepared from macrophages incubated for 30 min with IFN-g (Figure 6a ). In the probe with the mutated GAS1 box, no retarded bands were detected. As a control we used an oligonucleotide with a canonical GAS box. 29 To further characterize the interaction between the GAS1 box and transcription factors, competition experiments were performed. For this purpose, nuclear extracts obtained from macrophages after 30 min of interaction with IFN-g were used. As expected, the upper retarded band produced by the extracts can be competed by a 100 times excess of the same cold oligonucleotide, as well as the oligonucleotide containing the STAT1 canonical box (Figure 6b ). No competition was detected when we used an excess of oligonucleotide containing the GAS1 mutated or the IRF-1 box, suggesting that this band corresponds to STAT1. Similar results were obtained with the lower band. Next, we attempted to identify the factor that binds to the GAS1 box. For this purpose, we used a monoclonal antibody (Ab) against STAT1. This Ab, but not nonspecific immunoglobulins used as control, blocked the binding of nuclear extracts to the GAS1 probe (Figure 6c ). These results demonstrate that the induced protein that binds to the GAS1 sequence is specific and is recognized by anti-STAT1 Abs.
To characterize the other area of the promoter involved in regulation, we used nuclear extracts and an oligonucleotide covering the IRF-1 box. Nuclear extracts from macrophages treated for 2 h with IFN-g showed the induction of several complexes (Figure 7) . However, in the IRF-1 mutant and competition experiments, only one induced band was observed to bind specifically ( Figure  7) . To identify the complex that bound to this sequence, we used an Ab against IRF1. The Ab but not IgG controls inhibit the binding of the proteins to DNA suggesting that in the complex IRF1 is involved. Finally, using an oligonucleotide covering the area with the NFkB sequence, no retarded bands were found before or after IFN-g treatment (data not shown).
Discussion
Here, we characterize the transcriptional regulation of the murine Tap1 and Lmp2 genes by IFN-g. The products of these genes are peptide transporters that are required to provide peptides from endogenously synthesized proteins to the endoplasmic reticulum for MHC class I binding. Although IFN-g induces the expression of MHC class I molecules, it is particularly important for the expression of class II molecules by macrophages. 30 Several examples of the presentation of intracellular proteins with MHC class II molecules have been reported. 31, 32 Moreover, the TAP complex influences allorecognition of class II MHC molecules. 33 Therefore, IFN-g could be the critical cytokine that regulates the endogenously synthesized peptides presented by class II molecules.
Although in most of the cases, IFN-g induced the expression of Tap1 and Lmp2, there were considerable differences in their levels of expression. These differences Luc.
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are probably related to the type of cell line used in each study. For example, coordinated constitutive expression of Lmp2 and Tap1 genes has been described in HeLa cells 7 and in human small cell lung carcinoma cell lines, 34 while in melanoma cell lines only Tap1 is constitutively expressed. 22 It is for these reasons that we used primary cultures of BMDM. In contrast to these previous studies, we detected the constitutive expression of Lmp2 but not Tap1. When we used two distinct macrophage cell lines, Bac-1 F5a and Raw 264.7; only the latter showed a pattern of expression similar to primary cells. In human macrophages, constitutive expression of Tap1 and Lmp2 is observed in primary cultures, 35 while the former is absent in the THP-1 cell line. 16 In this model, after 24 h of treatment, IFN-g destabilized the mRNA and reduced the half-life from more than 24 h to only 4 h. 16 In contrast to these data, here we found that in primary murine macrophages, or in a cell line, mRNA induced by IFN-g after 24 h was very stable for Tap1 and Lmp2 genes. The binding of nuclear extracts from IFN-g-treated macrophages to the GAS1 box is specific. Nuclear extracts were prepared from BMDM incubated with IFN-g (300 U/ml) for 30 min. The probe was an oligonucleotide of 31 bases covering the GAS1 box. Competition experiments were made adding 100 times excess of the cold oligonucleotides indicated to the nuclear extracts before addition of the radiolabelled GAS1 oligonucleotide. Anti-STAT1 Ab or control IgG (2 mg) was added to extracts before the binding assay. Retarded complexes were detected by autoradiography. This experiment was performed three times and the results of one representative experiment are shown. 
Several areas in the bidirectional promoter of Tap1 and Lmp2 are susceptible to regulation by IFN-g. However, there are distinct requirements depending on the cell line. The presence of only the GAS box is necessary in HeLa cells 36 and in macrophagic cells. 14 By contrast, in a renal carcinoma cell line, IFN-g acts only through the IRF-1 sequence. 37 The role of IRF-1 in the regulation of Tap1 and Lmp2 genes has been proposed because of the paucity of CD8 þ T cells observed in IRF-1 À/À mice. 38 In some cases, such as in endothelial cells, the GAS and the IRF-1 boxes must be mutated to abolish the IFN-g response. 13 Finally, in some melanoma cell lines, binding to either IRF-1 or GAS boxes is sufficient to induce Tap1, but for Lmp2 the binding of both transcription factors is required. 22 Our results indicate that Tap1 and Lmp2 gene induction partially requires de novo protein synthesis. Thus, some elements that mediate the induction of these two genes in response to IFN-g are already synthesized in the cell at the moment of IFN-g stimulus and to either translocate to the nucleus or to suffer post-translational modifications while others elements need to be synthesized. In our functional studies, we found that mutation of either a precise GAS or IRF-1 box was sufficient to eliminate the IFN-g inducibility for Tap1 and Lmp2 genes. This is supported by our observation using macrophages from STAT1 knockout mice in which IFNg does not induce the expression of Tap1 or Lmp2 genes. In response to IFN-g, JAK1 and JAK2 are activated followed by STAT1 that form homodimers, translocate to the nucleus and bind a GAS sequence in the Tap1/Lmp2 promoter. 17 There is another GAS sequence in the promoter of the transcription factor IRF-1 which mediates its expression. 39 This explains the distinct kinetics of the retarded bands, which appeared in the GAS box after only 30 min (not protein synthesis needed) but required 3 h to be detected in the IRF-1 box. As the cells, due to the toxicity of cycloheximide, were incubated with the drug only for 1 h in the presence of IFN-g, this explains the partial requirement of the de novo protein synthesis. 38 Therefore, during the 3 h, IRF-1 protein is synthesized and translocated to the nucleolous where it binds to the IRF-1 sequence in the promoter and initiates transcription.
The differential constitutive expression of Lmp2 and Tap1 is not explained by our results on gene regulation. In fact, we have found that the same elements control the expression of both genes. There are examples of other genes that are divergently transcribed from a single promoter. The H2A and H2B genes in the Xenopus xlh3 histone gene cluster are divergently transcribed because of the activity of overlapping promoter sequences that share multiple regulatory elements. 40 Furthermore, the human and murine COL4A1 and COL4A2 genes are expressed discordantly, although they share the same promoter. Lack of binding activity at the CCAAT and CTC regions markedly reduces transcription of the COL4A2 gene, without affecting that of COLA1. 41 Constitutive Lmp2 expression is due to the binding of a complex of unphosphorylated STAT1 and IRF-1 to the partially overlapping interferon consensus sequence 2 (ICS2) and GAS sites in the human Lmp2 promoter. 19 In the murine promoter, this ICS2 sequence does not overlap with the GAS site and another mechanism may be involved in the constitutive expression of Lmp2. In our experimental system, we did not take into account several factors that may be crucial for the regulation of expression in vivo. For example, chromatin structures create barriers for each step in eukaryotic transcription and the remodelling of histones creates DNA templates that are accessible to the general transcription apparatus. 42 The way in which histones interact with the common promoter of Tap1 and Lmp2 may condition a distinct basal expression for each gene.
Materials and methods
Reagents IFN-g recombinant murine interferon IFN-g was kindly provided by Genentech (South San Francisco, CA, USA). Anti-STATt1a (sc-592X) was purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA) and nonspecific rabbit IgG was purchased from Sigma Cheminal (St Louis, MO, USA). All other chemicals were of the highest purity grade available and were purchased from Sigma Chemical. Deionized water further purified with a Millipore Milli-Q system A10 was used.
Cell culture BMDM were isolated from 6-week-old BALB/c mice (Charles River Laboratories, Wilmingyon, MA, USA) as previously described. 43 Macrophages were cultured in plastic tissue-culture dishes (150 mm) in 40 ml DMEM containing 20% fetal bovine serum (FBS) (Sigma) and 30% L-cell conditioned media as a source of macrophage colony-stimulating factor (M-CSF). 44 Penicillin/streptomycin was added. Cells were incubated at 371C in a humidified 5% CO 2 atmosphere. After 7 days of culture, macrophages were obtained as a homogenous population of adherent cells (499% Mac-1 þ ). To render cells quiescent, when they were 80% confluent they were deprived of L-cell-conditioned medium for 16-18 h before carrying out the experiments and were then subjected to the treatments. Macrophages from STAT1 knockout C57/BL6 mice and the corresponding WT controls were isolated under the same conditions. 27 STAT1 knockout mice were kindly donated by Dr RD Schreiber from the Washington University School of Medicine, St Louis, MI, USA. The murine fibroblast cell line L929, and the murine macrophage cell lines Raw 264.7 and Bac-1 F5a were cultured in DMEM media with 10% FBS without antibiotics at 371C with 5% CO 2 . For the Bac-1 F5a culture, M-CSF was added to the media.
Reporter plasmids
The Tap1/Lmp2 bidirectional promoter was cloned from murine genomic DNA isolated from L929 cells using restriction with EcoRI and PCR, following Marusina et al. 45 The full-length promoter fragment was cloned into the pCR2.1 vector (TA Cloning Kit, Invitrogen). The promoter was subcloned directionally into the Luciferase reporter plasmid pGL3-Basic (Promega Corp., Madison WI, USA), thereby obtaining two plasmids in function of their direction, both of which were in frame with the luciferase gene, named pGL3-tap1 and pGL3-lmp2. These two plasmids were sequenced. Mutations of individual binding sites were made using site-directed mutagenesis. The GAS1 box from -163 to -172 (TTTA-GAGGAA) was mutated for (TAGATCTCCC), the GAS2 box from -240 to -247 (TTCTGGAA) was mutated for (TGCTAGCC), the IRF-1 box from -177 to -187 (AAACCGAAAGC) was mutated for (CACGCTAGC-CA) and the NFkB box from -110 to -119 (GTAAAG TCCC) was mutated for (AGCTAGCACC). Two independent PCRs of the plasmids constructed were made. The first was made with the same 5 0 oligonucleotide used for the generation of the full-length promoter and a 3 0 primer containing the box sequence with a mutation. The second PCR was performed with the same 3 0 primer used for the entire promoter cloning and a 5 0 primer with the same mutation introduced in the first PCR. The fragments were cloned separately into the pCR2.1 vector and then restricted. Both inserts were ligated into the pGL3-Basic, obtaining the full-length promoter with the mutation. The oligonucleotides used to introduce the mutations contained the same mutated nucleotides as those described for the probes used in the DNA binding assays. pRL-BOS was used as a control of transfection. This plasmid expresses the renilla gene under the control of the BOS promoter.
Transient transfections and luciferase assays
To transfect Raw 264.7 cells, liposomal transfection reagent Fugene 6 (Boheringer Mannheim, Germany) was used, following the manufacturer's instructions. IFN-g stimulations were carried out 12 h after transfection. Cotransfection experiments with control plasmid pRL-BOS were made by adding 100 ng of the plasmid to the transfection reaction. Luciferase activity was measured with the Luciferase Dual System Assay (Promega, Mannheim, Germany) using standard procedures, on a TD-20/20 luminometer (Turner Designs, Sunnyvale, CA, USA). Transfection controls were made with pRL-BOS, and the same luminometer was used to measure renilla luciferase activity.
RNA extraction and Northern blot analysis
Cells were washed twice with cold PBS, and total RNA was extracted with the acidic guanidinium thiocyanatephenol-chloroform method as described. 46 Total cellular RNA samples (15 mg) were separated on 1.2% agarose gels with 5 mM MOPS (pH 7.0) and 1 M formaldehyde buffer. The RNA was transferred overnight to a nylon membrane (Genescreen; NEN Life Science Products, Boston, MA, USA) and fixed by UV irradiation (150 mJ). After incubating the membranes for 18 h at 651C in hybridization solution (20% formamide, 5 Â Denhardt's, 5 Â SSC, 10 mM EDTA, 1% SDS, 25 mM Na 2 HPO 4 , 25 mM NaH 2 PO 4 , 0.2 mg/ml salmon sperm DNA and 10 6 cpm/ml of 32 P-labelled probe), they were exposed to Kodak X-AR films (Kodak, Rochester, NY, USA). The bands of interest were quantified with a Molecular Analyst System (Bio-Rad Labs, Richmond, CA, USA). cDNA probes for mouse Tap1 and Lmp2 were prepared by RT-PCR. To prepare IAa, IL-1b, RNA 18S and L32 probes, plasmids containing corresponding cDNAs were digested with adequate restriction enzymes. All probes were labelled with [a-32 P]dCTP (ICN Pharmaceuticals) with the oligolabelling kit method (Pharmacia Biotech, Uppsala, Sweden).
Quantitative RT-PCR analysis RNA was treated with DNAse (Ambion, Austin, TX, USA) to eliminate contaminating DNA. For cDNA synthesis, 1 mg RNA and TaqMan reverse transcription reagents (including Multiscribe reverse transcriptase and random hexamers) were used, as described by the manufacturer (Applied Biosystems, Foster City, CA, USA). The primers and probes used to amplify mouse Tap1 were TTATCTTGGATGATGCCACCAG and AA-GAAGAACCGTCCGAGAAGC and Lmp-2 TACCGT-GAGGACTTGTTAGCGC and GGCTGTCGAATTAGC ATCCCT cDNA by real-time PCR were from Applied Biosystems. Real-time monitoring of PCR amplification of cDNAs was performed using the TaqMan Universal master mix (Applied Biosystems) in the ABI Prism 7700 Sequence Detection System (Applied Biosystems). The relative quantification of gene expression was performed as described in the TaqMan user's manual using b actin (GCACCACACCTTCTACAATGAGCTGT and CTGCTGGAAGTCTAGAGCAACATA). The threshold cycle (C T ) is defined as the cycle number at which the fluorescence corresponding to the amplified PCR product is detected. The PCR arbitrary units of each gene were defined as the mRNA levels normalized to the b actin expression level in each sample.
Nuclear extracts and EMSA analysis Nuclear extracts were prepared from BMDM as previously described, 47 with some modifications. Briefly, pellets of BMDM were washed twice with cold PBS buffer, followed by resuspention in five volumes of hypotonic buffer (10 mM HEPES (pH 7.9) at 41C, 1.5 mM MgCl 2 , 10mM KCl, 0.2 mM PMSF, 0.5 mM DTT) and centrifugation at 1500 rpm for 5 min at 41C. The pellet was resuspended in three volumes of hypotonic buffer and allowed to stand on ice for 10 min. The lysates were homogenized in a potter and the homogenate was centrifuged at 5000 rpm for 20 min at 41C to pellet crude nuclei. The nuclear pellet was resuspended in 1/2 vol low-salt buffer (20 mM HEPES, pH 7.9 at 41C, 1.5 mM MgCl 2 , 25% (v/v) glycerol, 20 mM KCl, 0.2 mM EDTA, 0.2 mM PMSF, 0.5 mM DTT), followed by the addition of 1/2 vol high-salt buffer (20 mM HEPES (pH 7.9) at 41C, 1.5 mM MgCl 2 , 25% (v/v) glycerol, 1.2 M KCl, 0.2 mM EDTA, 0.2 mM PMSF, 0.5 mM DTT). The crude nuclei were extracted at 41C for 30 min with continuous stirring, followed by centrifugation at 14 000 rpm for 30 min. Supernatants were dialyzed with the PlusOne Mini Dialysis Kit (Amersham Biosciences, San Francisco, CA, USA) in dialysis buffer (20 mM HEPES (pH 7.9), 20% (v/ v) glycerol, 100 mM KCl, 0.2 mM EDTA, 0.2 mM PMSF, 0.5 mM DTT) at 41C. The extracts were cleared by centrifugation at 14 000 rpm for 20 min and the supernatant was collected in aliquots and stored at À801C until use. Protein concentrations in the nuclear extracts were determined using the Bradford protein assay.
Electrophoretic mobility shift assays were performed as described. 48 Briefly, binding reactions were prepared with 6 mg of nuclear extracts and 20 000 cpm 32 P-labelled probe in the presence of 2 mg of poly(dI-dC), in a final volume of 15 ml containing 1 Â binding buffer (12 mM HEPES pH 7.9, 60 mM KCl, 5 mM MgCl 2 , 0.12 mM EDTA, 0.3 mM PMSF, 0.3 mM DTT, 12% glycerol). An 8 min preincubation of extracts and poly(dI-dC) was performed. Then the radiolabelled probe was added and incubated for an additional 15 min at room temperature. Samples were loaded onto 6% acrylamide gel containing 5% glycerol and 0.25% TBE, and electrophoresed at 41C. Band-shift gels were dried and bands were visualized by autoradiography. For supershift experiments, following the binding reaction, appropriate Abs were added and incubated for 30 min. For competition experiments, 100-fold excess of unlabelled primers were included in the binding reaction. Oligonucleotides used as probes in the assay were 5 0 -end labelled using T 4 Polynucleotide Kinase (USB Corporation, OH, USA). All of them were synthesized by Genotek (Barcelona, Spain) and correspond to the following regions of the Tap1/Lmp2 promoter: GAS1 5 0 -AGAAGTGCTGGCGTTTAGAG-GAAGAAGCACG-3 0 ; GAS1mut 5 0 -AGAAGTGCTGGC GTAGATCTCCCGAAGCACG-3 0 ; IRF-1 5 0 -CCCGAAGA AACCGAAAGCCGACCTCGAATCA-3 0 ; IRF-1mut 5 0 -CCCGAAGCACGCTAGCCACGACCTCGAATCA-3 0 . Canonical sequence for STAT1 5 0 -CATGTTATGCA-TATTCCTGTAAGTG-3 0 was used as a control. Oligonucleotides used as probes in EMSA assays contain the same mutated nucleotides as those used to introduce the mutations in reporter plasmids for luciferase assays.
